Once a year for two hours, a group of able-bodied students at the Massachusetts Institute of Technology take to the streets of Cambridge and their campus halls in wheelchairs, a news post by Alyssa Meyers recently published in the Boston Globe described. During another two-hour class period, they walk around the…

Study finds bacterial response to drugs varies in different environments. MIT and Harvard University researchers have engineered E. coli cells that can be used to study how bacteria at an infection site respond to antibiotic treatment, allowing scientists to learn more about how existing antibiotics work and potentially help them…

MEMP student Shriya Srinivasan, studying in the Harvard-MIT Health Sciences and Technology program (HST), the degree-granting educational arm of IMES, is featured in the September-October 2017 issue of Harvard Magazine for her work to improve the process for performing amputations. “Today’s state-of-the-art prosthetic limbs are scientific marvels, designed with robotics and sensors that…

Charles River has proudly partnered with the EBD Group to provide the scientific program for this year’s BioPharm America™ Conference. This exciting two-day program aims to bridge the gap between drug discovery and clinical application. Driven by the bedside-to-bench experience, industry leaders will come together to discuss innovations and breakthroughs…

Austin Huang ’09, a MEMP alum of the Harvard-MIT Health Sciences and Technology program (HST), the degree-granting program housed within the Institute for Medical Engineering and Science (IMES), recently represented Pfizer in the 2017 Aspen Ideas Festival. Huang is the Biomedical Data Science Lead for Computational Biomedicine / Genome Sciences and Technology…